BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs2300478
,
EGFR
,
T cell differentiation
,
Hepatitis
,
Lung
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pulegone
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
DLX5
PPP2R2D
EDNRA
DDX27
CTSH
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
response to organic substance
regulation of nitrogen compound metabolic process
cell differentiation
cytosol
enzyme binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
Mode of action of pulegone on the urinary bladder of F344 rats.
In vitro production of M. × piperita not containing pulegone and menthofuran.
Pharmacological activity of (R)-(+)-pulegone, a chemical constituent of essential oils.
IR-Raman-VCD study of R-(+)-pulegone: influence of the solvent.
Molecular response of Musca domestica L. to Mintostachys verticillata essential oil, (4R)+-pulegone …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for pulegone
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ